Clinical trial

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in…

NCT00026286 · Eastern Cooperative Oncology Group, Other · Completed

Key facts

NCT number NCT00026286
Title Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Official title A Phase III Prospective, Randomized, Double-Blind Clinical Trial of Hormone Replacement Therapy In Postmenopausal Women With A History Of Node-Negative Or Ductal Carcinoma In Situ Who Are Receiving Adjuvant Tamoxifen
Lead sponsor Eastern Cooperative Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Breast Cancer, Hot Flashes, Menopausal Symptoms
Intervention type Drug
Interventions conjugated estrogens, medroxyprogesterone
Start date Nov 28, 2000
Primary completion Aug 1, 2002
Completion Jun 15, 2007
First posted Sep 17, 2003
Last update posted Jun 15, 2023
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies